IHS Chemical Week

Regions :: China

Evonik API site in China receives written confirmation of EU GMP compliance

11:24 AM MDT | October 28, 2013 | Deepti Ramesh

Evonik Industries says that it was one of the first active pharmaceutical ingredient (API)–producing companies in China to be granted written confirmations by the Guangxi Food and Drug Administration for all products manufactured at the company's site at Wuming, China. These confirmations certify that the facility operates in accordance with EU GMP requirements. As of 2 July, the compliance of APIs manufactured outside and imported into the EU must be confirmed in writing by a competent authority of the exporting country. This document must also...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa